Dr. Ari VanderWalde, MD, MPH
Claim this profileWest Cancer Center
Studies Cancer
Studies Skin Cancer
3 reported clinical trials
6 drugs studied
Area of expertise
1Cancer
Stage IV
BRAF positive
MSI-H positive
2Skin Cancer
Stage IV
BRAF positive
MSI-H positive
Affiliated Hospitals
Clinical Trials Ari VanderWalde, MD, MPH is currently running
Combination Drug Therapy
for Cancer
This is an open-label, single-arm, Phase 2 study which will evaluate the efficacy and safety of niraparib and dostarlimab (TSR-042) combination in patients with metastatic, recurrent, or unresectable solid tumor with a pathogenic, or presumed pathogenic, somatic homologous recombination deficiency (HRD) gene mutation
Recruiting1 award Phase 2
RP1 + Nivolumab
for Cancer
This trial tests a modified virus (RP1) and an immune-boosting drug (nivolumab) in adults with advanced or treatment-resistant solid tumors. RP1 kills cancer cells and helps the immune system recognize them, while nivolumab enhances the immune response. Nivolumab has been approved for treating advanced melanoma, renal cell carcinoma, non-small cell lung cancer, and other malignancies.
Recruiting1 award Phase 29 criteria
More about Ari VanderWalde, MD, MPH
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ari VanderWalde, MD, MPH has experience with
- Nivolumab
- RP1
- Ipilimumab
- Relatlimab
- BMS-986205
- Niraparib And Dostarlimab
Breakdown of trials Ari VanderWalde, MD, MPH has run
Skin Cancer
Microsatellite Instability
Melanoma
Non-melanoma Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ari VanderWalde, MD, MPH specialize in?
Ari VanderWalde, MD, MPH focuses on Cancer and Skin Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Ari VanderWalde, MD, MPH currently recruiting for clinical trials?
Yes, Ari VanderWalde, MD, MPH is currently recruiting for 2 clinical trials in Germantown Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Ari VanderWalde, MD, MPH has studied deeply?
Yes, Ari VanderWalde, MD, MPH has studied treatments such as Nivolumab, RP1, Ipilimumab.
What is the best way to schedule an appointment with Ari VanderWalde, MD, MPH?
Apply for one of the trials that Ari VanderWalde, MD, MPH is conducting.
What is the office address of Ari VanderWalde, MD, MPH?
The office of Ari VanderWalde, MD, MPH is located at: West Cancer Center, Germantown, Tennessee 38138 United States. This is the address for their practice at the West Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.